360 related articles for article (PubMed ID: 26656946)
1. Rifabutin-loaded solid lipid nanoparticles for inhaled antitubercular therapy: Physicochemical and in vitro studies.
Gaspar DP; Faria V; Gonçalves LM; Taboada P; Remuñán-López C; Almeida AJ
Int J Pharm; 2016 Jan; 497(1-2):199-209. PubMed ID: 26656946
[TBL] [Abstract][Full Text] [Related]
2. Microencapsulated SLN: An innovative strategy for pulmonary protein delivery.
Gaspar DP; Serra C; Lino PR; Gonçalves L; Taboada P; Remuñán-López C; Almeida AJ
Int J Pharm; 2017 Jan; 516(1-2):231-246. PubMed ID: 27864069
[TBL] [Abstract][Full Text] [Related]
3. Microencapsulated Solid Lipid Nanoparticles as a Hybrid Platform for Pulmonary Antibiotic Delivery.
Gaspar DP; Gaspar MM; Eleutério CV; Grenha A; Blanco M; Gonçalves LMD; Taboada P; Almeida AJ; Remuñán-López C
Mol Pharm; 2017 Sep; 14(9):2977-2990. PubMed ID: 28809501
[TBL] [Abstract][Full Text] [Related]
4. Physicochemical characterization of sildenafil-loaded solid lipid nanoparticle dispersions (SLN) for pulmonary application.
Paranjpe M; Finke JH; Richter C; Gothsch T; Kwade A; Büttgenbach S; Müller-Goymann CC
Int J Pharm; 2014 Dec; 476(1-2):41-9. PubMed ID: 25261709
[TBL] [Abstract][Full Text] [Related]
5. Long-term stability, biocompatibility and oral delivery potential of risperidone-loaded solid lipid nanoparticles.
Silva AC; Kumar A; Wild W; Ferreira D; Santos D; Forbes B
Int J Pharm; 2012 Oct; 436(1-2):798-805. PubMed ID: 22867992
[TBL] [Abstract][Full Text] [Related]
6. Characterization of ergocalciferol loaded solid lipid nanoparticles.
Patel MR; San Martin-Gonzalez MF
J Food Sci; 2012 Jan; 77(1):N8-13. PubMed ID: 22260120
[TBL] [Abstract][Full Text] [Related]
7. Design of a nanostructured lipid carrier intended to improve the treatment of tuberculosis.
Pinheiro M; Ribeiro R; Vieira A; Andrade F; Reis S
Drug Des Devel Ther; 2016; 10():2467-75. PubMed ID: 27536067
[TBL] [Abstract][Full Text] [Related]
8. Development and Evaluation of Chitosan Microparticles Based Dry Powder Inhalation Formulations of Rifampicin and Rifabutin.
Pai RV; Jain RR; Bannalikar AS; Menon MD
J Aerosol Med Pulm Drug Deliv; 2016 Apr; 29(2):179-95. PubMed ID: 26406162
[TBL] [Abstract][Full Text] [Related]
9. Novel approach for overcoming the stability challenges of lipid-based excipients. Part 3: Application of polyglycerol esters of fatty acids for the next generation of solid lipid nanoparticles.
Corzo C; Meindl C; Lochmann D; Reyer S; Salar-Behzadi S
Eur J Pharm Biopharm; 2020 Jul; 152():44-55. PubMed ID: 32387704
[TBL] [Abstract][Full Text] [Related]
10. Spray-dried fucoidan microparticles for pulmonary delivery of antitubercular drugs.
Cunha L; Rosa da Costa AM; Lourenço JP; Buttini F; Grenha A
J Microencapsul; 2018 Jun; 35(4):392-405. PubMed ID: 30112917
[TBL] [Abstract][Full Text] [Related]
11. Design, characterization and in vitro evaluation of linalool-loaded solid lipid nanoparticles as potent tool in cancer therapy.
Rodenak-Kladniew B; Islan GA; de Bravo MG; Durán N; Castro GR
Colloids Surf B Biointerfaces; 2017 Jun; 154():123-132. PubMed ID: 28334689
[TBL] [Abstract][Full Text] [Related]
12. Delivery of retinoic acid to LNCap human prostate cancer cells using solid lipid nanoparticles.
Akanda MH; Rai R; Slipper IJ; Chowdhry BZ; Lamprou D; Getti G; Douroumis D
Int J Pharm; 2015 Sep; 493(1-2):161-71. PubMed ID: 26200751
[TBL] [Abstract][Full Text] [Related]
13. Lopinavir loaded solid lipid nanoparticles (SLN) for intestinal lymphatic targeting.
Aji Alex MR; Chacko AJ; Jose S; Souto EB
Eur J Pharm Sci; 2011 Jan; 42(1-2):11-8. PubMed ID: 20971188
[TBL] [Abstract][Full Text] [Related]
14. Lipid Nanocarrier-Mediated Drug Delivery System to Enhance the Oral Bioavailability of Rifabutin.
Nirbhavane P; Vemuri N; Kumar N; Khuller GK
AAPS PharmSciTech; 2017 Apr; 18(3):829-837. PubMed ID: 27350276
[TBL] [Abstract][Full Text] [Related]
15. Optimization of nimesulide-loaded solid lipid nanoparticles (SLN) by factorial design, release profile and cytotoxicity in human Colon adenocarcinoma cell line.
Campos JR; Fernandes AR; Sousa R; Fangueiro JF; Boonme P; Garcia ML; Silva AM; Naveros BC; Souto EB
Pharm Dev Technol; 2019 Jun; 24(5):616-622. PubMed ID: 30477410
[TBL] [Abstract][Full Text] [Related]
16. Effect of freeze-drying, cryoprotectants and storage conditions on the stability of secondary structure of insulin-loaded solid lipid nanoparticles.
Soares S; Fonte P; Costa A; Andrade J; Seabra V; Ferreira D; Reis S; Sarmento B
Int J Pharm; 2013 Nov; 456(2):370-81. PubMed ID: 24036086
[TBL] [Abstract][Full Text] [Related]
17. Inhalable chitosan microparticles for simultaneous delivery of isoniazid and rifabutin in lung tuberculosis treatment.
Cunha L; Rodrigues S; Rosa da Costa AM; Faleiro L; Buttini F; Grenha A
Drug Dev Ind Pharm; 2019 Aug; 45(8):1313-1320. PubMed ID: 30990096
[TBL] [Abstract][Full Text] [Related]
18. Self-reporter shikonin-Act-loaded solid lipid nanoparticle: formulation, physicochemical characterization and geno/cytotoxicity evaluation.
Eskandani M; Nazemiyeh H
Eur J Pharm Sci; 2014 Aug; 59():49-57. PubMed ID: 24768857
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the digestibility of solid lipid nanoparticles of glyceryl dibehenate produced by two techniques: Ultrasonication and spray-flash evaporation.
Jannin V; Blas L; Chevrier S; Miolane C; Demarne F; Spitzer D
Eur J Pharm Sci; 2018 Jan; 111():91-95. PubMed ID: 28966096
[TBL] [Abstract][Full Text] [Related]
20. Formulation, optimization, and characterization of rifampicin-loaded solid lipid nanoparticles for the treatment of tuberculosis.
Chokshi NV; Khatri HN; Patel MM
Drug Dev Ind Pharm; 2018 Dec; 44(12):1975-1989. PubMed ID: 30058392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
